Literature DB >> 23882096

The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"?

Stephanie Nougaret1, Caroline Reinhold, Hisham W Mikhael, Philippe Rouanet, Frédéric Bibeau, Gina Brown.   

Abstract

Rectal cancer is a common and serious disease in the Western hemisphere. Optimal treatment of rectal cancer involves a multidisciplinary approach, with collaboration required between radiologists, oncologists, surgeons, and pathologists to achieve local control and decrease the rate of recurrence. Several studies have been published that show the ability to accurately stage rectal cancer with magnetic resonance (MR) imaging. Moreover, advances in preoperative therapies require accurate preoperative staging with MR imaging to select those patients who may benefit from more intensive treatment, without subjecting those who will not benefit to unnecessary treatment. As we enter an era of individualized patient care, stratified according to the risk of both local and distant failure, imaging takes on the same importance as the tumor type and genetic susceptibility. MR imaging is now an essential tool to enable the oncology team to make appropriate treatment decisions. However, rectal cancer evaluation with MR imaging remains a challenge in the hands of nonexperts. This article describes a mnemonic device, "DISTANCE," to enable a systematic approach to the interpretation of MR images, thereby enabling all the clinically relevant features to be adequately assessed: DIS, for Distance from the Inferior part of the tumor to the transitional Skin; T, for T staging; A, for Anal complex; N, for Nodal staging; C, for Circumferential resection margin; and E, for Extramural vascular invasion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23882096     DOI: 10.1148/radiol.13121361

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  53 in total

Review 1.  MRI Local Staging and Restaging in Rectal Cancer.

Authors:  Gregory dePrisco
Journal:  Clin Colon Rectal Surg       Date:  2015-09

Review 2.  Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Authors:  Yulia Lakhman; Stephanie Nougaret; Maura Miccò; Chiara Scelzo; Hebert A Vargas; Ramon E Sosa; Elizabeth J Sutton; Dennis S Chi; Hedvig Hricak; Evis Sala
Journal:  Radiographics       Date:  2015 Jul-Aug       Impact factor: 5.333

3.  Radiogenomics of rectal adenocarcinoma in the era of precision medicine: A pilot study of associations between qualitative and quantitative MRI imaging features and genetic mutations.

Authors:  Natally Horvat; Harini Veeraraghavan; Raphael A Pelossof; Maria Clara Fernandes; Arshi Arora; Monika Khan; Michael Marco; Chin-Tung Cheng; Mithat Gonen; Jennifer S Golia Pernicka; Marc J Gollub; Julio Garcia-Aguillar; Iva Petkovska
Journal:  Eur J Radiol       Date:  2019-02-18       Impact factor: 3.528

4.  Rectal endometriosis: predictive MRI signs for segmental bowel resection.

Authors:  Pascal Rousset; Guillaume Buisson; Jean-Christophe Lega; Mathilde Charlot; Colin Gallice; Eddy Cotte; Laurent Milot; François Golfier
Journal:  Eur Radiol       Date:  2020-08-26       Impact factor: 5.315

5.  Can Post-Treatment MRI Features Predict Pathological Circumferential Resection Margin (pCRM) Involvement in Low Rectal Tumors.

Authors:  A Patra; A D Baheti; S K Ankathi; A Desouza; R Engineer; V Ostwal; A Ramaswamy; A Saklani
Journal:  Indian J Surg Oncol       Date:  2020-09-22

6.  Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance.

Authors:  Eun Sun Lee; Min Ju Kim; Sung Chan Park; Bo Yun Hur; Jong Hee Hyun; Hee Jin Chang; Ji Yeon Baek; Sun Young Kim; Dae Yong Kim; Jae Hwan Oh
Journal:  Eur Radiol       Date:  2017-08-07       Impact factor: 5.315

7.  Improving the completeness of structured MRI reports for rectal cancer staging.

Authors:  Anna H Zhao; Shanna A Matalon; Atul B Shinagare; Leslie K Lee; Giles W Boland; Ramin Khorasani
Journal:  Abdom Radiol (NY)       Date:  2020-09-19

8.  The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.

Authors:  Inês Santiago; Maria Barata; Nuno Figueiredo; Oriol Parés; Vanessa Henriques; António Galzerano; Carlos Carvalho; Celso Matos; Richard J Heald
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

9.  MRI can be used to assess advanced T-stage colon carcinoma as well as rectal carcinoma.

Authors:  Akitoshi Inoue; Shinichi Ohta; Norihisa Nitta; Masahiro Yoshimura; Tomoharu Shimizu; Masaji Tani; Ryoji Kushima; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2016-10-18       Impact factor: 2.374

10.  Coregistration of Preoperative MRI with Ex Vivo Mesorectal Pathology Specimens to Spatially Map Post-treatment Changes in Rectal Cancer Onto In Vivo Imaging: Preliminary Findings.

Authors:  Jacob Antunes; Satish Viswanath; Justin T Brady; Benjamin Crawshaw; Pablo Ros; Scott Steele; Conor P Delaney; Raj Paspulati; Joseph Willis; Anant Madabhushi
Journal:  Acad Radiol       Date:  2018-01-19       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.